Development and validation of HPTLC method for identification and quantification of sterols from leaves of Erythroxylum monogynum Roxb. and in vitro evaluation of anti-oxidant and anti-glycation activities

Guggulothu Hima bindu, S. Ravi Kiran

South African Journal of Botany · 2020 · 11 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

The petroleum ether extract from leaves of Erythroxylum monogynum when subjected to phytochemical analysis and chromatographic purification, resulted in the isolation of two new sterols namely 4-methyl ergosta-7, 23‑dien‑3β-ol and 4-methyl ergosta-7, 24 (28)‑dien‑3β-ol. Their structure was elucidated by NMR and Mass Spectrometry. The two sterols were separated on a silica gel 60F254 HPTLC plates impregnated with AgNO3 using dichloromethane: methanol (9:1 v/v) as a mobile phase. Upon densitometric scanning at 254 nm in a reflectance mode, the two sterols separated as sharp and compact bands with Rf of 0.47±0.02 and 0.52±0.01 respectively for 4-methyl ergosta-7, 23‑dien‑3β-ol and 4-methyl ergosta-7, 24 (28)‑dien‑3β-ol. Linear regression and calibration plots constructed (n = 6) showed excellent linearity at 100–500 ng per spot with a correlation coefficient, r = 0.9979±0.0004 and 0.9974±0.0007 for 4-methyl ergosta-7,23‑dien‑3β-ol and 4-methyl ergosta-7,24 (28)‑dien‑3β-ol, respectively. The Limits of detection and quantification were found to be 21.07 ng and 57.23 ng/band for 4-methyl ergosta-7,23‑dien‑3β-ol and 25.18 ng and 63.86 ng/band for 4-methyl ergosta-7,24 (28)‑dien‑3β-ol, respectively. Both the sterols demonstrated good anti-oxidant and anti-glycation activities where, the IC50 values obtained were comparable with the positive control compounds, ascorbic acid and aminoguanidine. The 4-methyl ergosta-7,23‑dien‑3β-ol displayed 100% anti-oxidant activity at 100 µg/ml for both DPPH and H2O2 scavenging assays. In addition, both the sterols presented more than 90% inhibition of Advanced Glycation End products at 100 µg/ml concentration. The results obtained are remarkable indicating that these plant extracts could serve as a natural alternative to the conventional oral hypoglycemic molecules.

References

23